Results 21 to 30 of about 19,875 (210)

Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines. [PDF]

Hum Vaccin Immunother
Wanlapakorn N, Sarawanangkoor N, Srimuan D, Thatsanathorn T, Thongmee T, Poovorawan Y.   +5 more
europepmc   +3 more sources

Combination Vaccination With Tetanus Toxoid and Enhanced Tumor-Cell Based Vaccine Against Cervical Cancer in a Mouse Model

Frontiers in Immunology, 2020
Cervical cancer is the fourth most common cancer in women with an estimated 570,000 new cases in 2018 which constitute about 6. 6% of all cancers in women according to WHO report 2018.
Donia Alson, Scott C. Schuyler, Scott C. Schuyler, Scott C. Schuyler, Bo-Xin Yan, Karthika Samimuthu, Jiantai Timothy Qiu, Jiantai Timothy Qiu   +7 more
doaj   +1 more source

Individual and community-level determinants of poor tetanus toxoid immunization among pregnant women in Ethiopia using data from 2016 Ethiopian demographic and health survey; multilevel analysis

Archives of Public Health, 2021
Background Tetanus is a vaccine-preventable disease that can occur in all populations, with neonates and pregnant women being at the most risk. Ethiopia has the highest maternal and neonatal tetanus morbidity and mortality rates.
Alemneh Mekuriaw Liyew, Hiwotie Getaneh Ayalew   +1 more
doaj   +1 more source

Differentials in prevalence and correlates on uptake of tetanus toxoid and intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy: A community-based cross-sectional study in The Gambia

SAGE Open Medicine, 2022
Objectives: The study examined the differentials in prevalence and correlates on the uptake of tetanus toxoid and intermittent preventive treatment of malaria among pregnant women in The Gambia.
Amadou Barrow, Sulayman Barrow, Amienatta Jobe   +2 more
doaj   +1 more source

Awareness and Uptake of Tetanus Toxoid Vaccination Among Females of Reproductive Age in Rawalpindi

Pakistan Armed Forces Medical Journal, 2023
Objectives: To determine awareness and uptake of tetanus toxoid vaccination among females of reproductive age in Rawalpindi, Pakistan. Study Design: Cross-sectional study. Place and Duration of Study: Fauji Foundation Hospital, Rawalpindi Pakistan,
Shumaila Humayun, Naila Azam
doaj   +1 more source

Decline of Tetanus Antitoxin Level with Age in Taiwan

Journal of the Formosan Medical Association, 2009
Tetanus is caused by Clostridium tetani, and is a vaccine-preventable infectious disease. The purpose of this study was to investigate the degree of protective tetanus immunity among adolescents and adults in Taiwan, which may provide valuable ...
Chi-Jung Wu, Huei-Chen Ko, Hsin-Chun Lee, Wei-Chuan Tsai, Min-Gi Li, Yu-Zhen Pao, Nan-Yao Lee, Chia-Ming Chang, Hsin-I Shih, Wen-Chien Ko   +9 more
doaj   +1 more source

Knowledge about and preventive practices against neonatal tetanus among young Nigerian women

Tzu Chi Medical Journal, 2019
Objective: The objective of this study was carried out to determine the knowledge about and preventive practices against neonatal tetanus (NNT) in young women of reproductive age.
C A Adegbenro, Samuel Anu Olowookere, F O Fehintola, P A Adegbenro, O T Orioke   +4 more
doaj   +1 more source

Phage display-based selection of high-affinity recombinant antibodies targeting tetanus toxoid [PDF]

Cellular, Molecular and Biomedical Reports
Despite the availability of effective vaccines, tetanus continues to pose a significant global health challenge, particularly among under-immunized populations.
Reza Yekani, Ali Nazari Shirvan, Mojtaba Noofeli, Maedeh Samianifard, Maliheh Entezari, Maedeh Kiani, Sepideh Sabbagh Kalat, Mehrshad Fekri   +7 more
doaj   +1 more source

Progress and barriers towards maternal and neonatal tetanus elimination in the remaining 12 countries: a systematic review

The Lancet Global Health, 2021
Summary: This systematic review assessed the progress and barriers towards maternal and neonatal tetanus elimination in the 12 countries that are yet to achieve elimination, globally. Coverage of at least 80% (the coverage level required for elimination)
Nasir Yusuf, MD, Azhar A Raza, MD, Diana Chang-Blanc, MPH, Bilal Ahmed, MBBS, Tedbabe Hailegebriel, MD, Richard R Luce, MD, Patricia Tanifum, MD, Balcha Masresha, MD, Mehoundo Faton, MD, Mohamed D Omer, MBBS, Saadia Farrukh, MBBS, Khin D Aung, MD, Heather M Scobie, PhD, Rania A Tohme, MD   +13 more
doaj   +1 more source

The monoclonal antibody 26 raised against tetanus toxoid also recognizes tetanus toxin and b2-glycoprotein I – its binding properties in vitro and potential applications [PDF]

Journal of the Serbian Chemical Society, 2009
A murine monoclonal IgG1 antibody, marked as MAb26, specific for tetanus toxoid has been immunochemically characterized. By performing enzyme-linked immunosorbent assays (ELISAs) and western blot analyses, it was demonstrated that MAb26 reacted with ...
ALEKSANDRA B. INIĆ-KANADA, MARIJANA M. STOJANOVIĆ, IRENA P. ŽIVKOVIĆ, VLADIMIR Ž. PETRUŠIĆ, LJILJANA A. DIMITRIJEVIĆ   +4 more
doaj